Covered recipient · General Payments record
KATHERINE ANN CARROLL
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2023
$2,733.35
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $269.22 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $41.01 | 2 |
| Biogen, Inc. | $31.06 | 2 |
| Otsuka America Pharmaceutical, Inc. | $28.72 | 2 |
| EMD Serono, Inc. | $28.66 | 2 |
| ARGENX US, INC. | $24.67 | 1 |
| Tris Pharma Inc | $23.35 | 1 |
| IMPEL PHARMACEUTICALS INC. | $21.69 | 1 |
| Amneal Pharmaceuticals LLC | $19.03 | 1 |
| Lundbeck LLC | $19.02 | 1 |
| EISAI INC. | $18.70 | 1 |
| UCB, Inc. | $13.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.17 | 01/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003349697 | CMS |
| ABBVIE INC. | $18.84 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003349701 | CMS |
| Amneal Pharmaceuticals LLC | $19.03 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053554889 | CMS |
| ARGENX US, INC. | $24.67 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060427093 | CMS |
| Biogen, Inc. | $15.53 | 04/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012280679 | CMS |
| Biogen, Inc. | $15.53 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012274249 | CMS |
| Eisai Inc. | $18.70 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023348931 | CMS |
| EMD Serono, Inc. | $14.33 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032543335 | CMS |
| EMD Serono, Inc. | $14.33 | 08/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032365873 | CMS |
| IMPEL PHARMACEUTICALS INC. | $21.69 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989414459 | CMS |
| Lundbeck LLC | $19.02 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032467089 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.88 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015055223 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.84 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015055231 | CMS |
| Tris Pharma Inc | $23.35 | 07/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059355899 | CMS |
| UCB, Inc. | $13.31 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021774853 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.